Skip to main content

Mettler-Toledo International(MTD-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1,162.77
Day High1,186.51
Open:1,178.26
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Mettler-Toledo International

Select a category then submit the form to load news
Zacks Investment Research
Buy 5 Non-Tech Wide Moat Stocks to Enhance Your Portfolio Returns
Buy 5 Non-Tech Wide Moat Stocks to Enhance Your Portfolio Returns
StockStory
3 Healthcare Stocks Walking a Fine Line
MTD
StockStory
5 Must-Read Analyst Questions From Mettler-Toledo’s Q4 Earnings Call
MTD
Tipranks
Analysts Conflicted on These Healthcare Names: Mettler-Toledo (MTD), Nuvation Bio (NUVB) and Mereo Biopharma Group Plc (MREO)
Tipranks
Mettler-Toledo Earnings Call Highlights Resilient Growth Path
Tipranks
Analysts’ Top Healthcare Picks: Mettler-Toledo (MTD), Abbott Laboratories (ABT)
Tipranks
Stifel Nicolaus Keeps Their Buy Rating on Mettler-Toledo (MTD)
Tipranks
Barclays Sticks to Its Buy Rating for Mettler-Toledo (MTD)
StockStory
MTD Q4 Deep Dive: Broad-Based Growth Balanced by Mixed Guidance and Margin Headwinds
MTD
StockStory
Mettler-Toledo (NYSE:MTD) Posts Better-Than-Expected Sales In Q4 CY2025
MTD
StockStory
What To Expect From Mettler-Toledo’s (MTD) Q4 Earnings
MTD
StockStory
1 Cash-Producing Stock with Solid Fundamentals and 2 We Brush Off
HUBS
Tipranks
Mettler-Toledo Adds Experienced Independent Director to Board
StockStory
3 Profitable Stocks We Find Risky
MTD
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
StockStory
1 High-Flying Stock on Our Watchlist and 2 We Question
EXAS
StockStory
3 Mid-Cap Stocks with Questionable Fundamentals
IEX
StockStory
1 Volatile Stock for Long-Term Investors and 2 We Avoid
AOUT
Tipranks
Barclays Sticks to Their Buy Rating for Mettler-Toledo (MTD)
StockStory
Q3 Earnings Highs And Lows: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Research Tools & Consumables Stocks
MTD
StockStory
1 S&P 500 Stock with Promising Prospects and 2 Facing Challenges
WDAY
StockStory
3 Profitable Stocks We’re Skeptical Of
UPST
Business Wire
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Business Wire
Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences
StockStory
3 Reasons to Sell MTD and 1 Stock to Buy Instead
MTD
Tipranks
Mettler-Toledo (MTD) Gets a Buy from Barclays
StockStory
5 Insightful Analyst Questions From Mettler-Toledo’s Q3 Earnings Call
MTD
Tipranks
J.P. Morgan Keeps Their Hold Rating on Mettler-Toledo (MTD)
StockStory
1 Healthcare Stock with Impressive Fundamentals and 2 Facing Headwinds
NTRA
Tipranks
Mettler-Toledo Earnings Call: Mixed Sentiment with Optimistic 2026 Outlook
Tipranks
Stifel Nicolaus Sticks to Its Buy Rating for Mettler-Toledo (MTD)
Tipranks
Mettler-Toledo (MTD) Gets a Buy from Barclays

Profile

Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.